BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26092281)

  • 1. HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia.
    Tian C; Yu Y; Jia Y; Zhu L; Zhang Y
    Ann Hematol; 2015 Sep; 94(9):1477-83. PubMed ID: 26092281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch activation inhibits AML growth and survival: a potential therapeutic approach.
    Kannan S; Sutphin RM; Hall MG; Golfman LS; Fang W; Nolo RM; Akers LJ; Hammitt RA; McMurray JS; Kornblau SM; Melnick AM; Figueroa ME; Zweidler-McKay PA
    J Exp Med; 2013 Feb; 210(2):321-37. PubMed ID: 23359069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hes1 suppresses acute myeloid leukemia development through FLT3 repression.
    Kato T; Sakata-Yanagimoto M; Nishikii H; Ueno M; Miyake Y; Yokoyama Y; Asabe Y; Kamada Y; Muto H; Obara N; Suzukawa K; Hasegawa Y; Kitabayashi I; Uchida K; Hirao A; Yagita H; Kageyama R; Chiba S
    Leukemia; 2015 Mar; 29(3):576-85. PubMed ID: 25234168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisis.
    Uchida T; Kitaura J; Nakahara F; Togami K; Inoue D; Maehara A; Nishimura K; Kawabata KC; Doki N; Kakihana K; Yoshioka K; Izawa K; Oki T; Sada A; Harada Y; Ohashi K; Katayama Y; Matsui T; Harada H; Kitamura T
    Exp Hematol; 2014 May; 42(5):369-379.e3. PubMed ID: 24486648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effects of Hes1 on acute myeloid leukemia cells].
    Tian C; Jia Y; Hu D; Li C; Qu F; Zhang Y
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):485-8. PubMed ID: 26134013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
    Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
    Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR‑135a predicts poor prognosis in acute myeloid leukemia and regulates leukemia progression via modulating HOXA10 expression.
    Xu H; Wen Q
    Mol Med Rep; 2018 Jul; 18(1):1134-1140. PubMed ID: 29845297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
    Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
    J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression.
    Kannan S; Fang W; Song G; Mullighan CG; Hammitt R; McMurray J; Zweidler-McKay PA
    Blood; 2011 Mar; 117(10):2891-900. PubMed ID: 21224467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway.
    Lee JH; Suk J; Park J; Kim SB; Kwak SS; Kim JW; Lee CH; Byun B; Ahn JK; Joe CO
    Mol Cancer Res; 2009 Oct; 7(10):1663-71. PubMed ID: 19808903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.
    Bennani-Baiti IM; Aryee DN; Ban J; Machado I; Kauer M; Mühlbacher K; Amann G; Llombart-Bosch A; Kovar H
    J Pathol; 2011 Nov; 225(3):353-63. PubMed ID: 21984123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma.
    Giovannini C; Gramantieri L; Minguzzi M; Fornari F; Chieco P; Grazi GL; Bolondi L
    Am J Pathol; 2012 Aug; 181(2):413-22. PubMed ID: 22705236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
    Katoh M; Katoh M
    Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
    Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation.
    Wendorff AA; Koch U; Wunderlich FT; Wirth S; Dubey C; Brüning JC; MacDonald HR; Radtke F
    Immunity; 2010 Nov; 33(5):671-84. PubMed ID: 21093323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
    J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.
    Espinosa L; Cathelin S; D'Altri T; Trimarchi T; Statnikov A; Guiu J; Rodilla V; Inglés-Esteve J; Nomdedeu J; Bellosillo B; Besses C; Abdel-Wahab O; Kucine N; Sun SC; Song G; Mullighan CC; Levine RL; Rajewsky K; Aifantis I; Bigas A
    Cancer Cell; 2010 Sep; 18(3):268-81. PubMed ID: 20832754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.